Sponsor of the Day:
Jerkmate
https://www.brighamhealthonamission.org/2024/04/11/researchers-discover-role-of-pd-1-in-driving-growth-of-merkel-cell-carcinoma/
Researchers Discover Role of PD-1 in Driving Growth of Merkel Cell Carcinoma - Brigham On a Mission
Dec 17, 2024 - In a study published in Science Advances, investigators reported for the first time that Merkel cell carcinoma cells express programmed cell death 1 (PD-1).
merkel cell carcinomaresearchers discoverpd 1driving growthrole
https://www.thespec.com/globenewswire/junshi-biosciences-presents-results-from-js207-pd-1vegf-bsab-phase-2-combo-studies-and-js212-egfrher3-adc-fih-phase-12-study-at-aacr-2026/article_0041e563-0a2a-5ea0-beef-2a942c007ecd.html
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212...
Apr 20, 2026 - SHANGHAI, April 20, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven...
pd 1phase 2biosciencespresentsresults
https://www.technologynetworks.com/applied-sciences/products/invivoplus-anti-mouse-pd-1-cd279-409551
InVivoPlus anti-mouse PD-1 (CD279) | Technology Networks
InVivoPlus anti mouse PD-1 (CD279) blocks PD-1 binding to PD-L1 and PD-L2 to suppress inhibitory signaling and restore T cell activity making it a powerful tool
pd 1technology networksantimouse
https://pdb101.rcsb.org/motm/204
PDB-101: Molecule of the Month: PD-1 (Programmed Cell Death Protein 1)
PD-1 and its ligands are a new target for cancer therapy
pdb 101 moleculecell deathmonthprogrammedprotein
https://research.tue.nl/nl/publications/artificial-intelligence-detected-tumor-infiltrating-lymphocytes-a/
Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based...
artificial intelligencetumor infiltratingpd 1detectedlymphocytes
https://www.e-trd.org/journal/view.php?doi=10.4046/trd.2025.0133
Serial KL-6 Changes in PD-1/PD-L1 Inhibitor-Related Pneumonitis in Non-small Cell Lung Cancer: A...
Serial KL-6 Changes in PD-1/PD-L1 Inhibitor-Related Pneumonitis in Non-small Cell Lung Cancer: A Single-Center Prospective Pilot Study
non small cell6 changespd 1lung cancerserial
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.731798/full
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
May 2, 2026 - Programmed cell death protein 1 (PD-1) is a common immunosuppressive molecule on the surface of T cells and plays an important role in downregulating the imm...
pd 1checkpoint inhibitorsfrontiersl1tumor
https://excli.de/excli/article/view/9096
Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and...
EXCLI Journal - Experimental and Clinical Sciences, International Online Journal for Advances in Sciences
pd 1immune checkpointefficacysafetyctla
https://www.biopharmadive.com/news/pd1-vegf-inhibitors-cancer-immunotherapy-bispecific-startups/741231/
Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda | BioPharma Dive
Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of research practically overnight.
pd 1cancer drugsbiopharma diveblockingvegf